XPH ETF
State Street SPDR S&P Pharmaceuticals ETF
XPH ETF Overview
XPH ETF (State Street SPDR S&P Pharmaceuticals ETF) is managed by State Street Investment Management with $527.7M in net assets. XPH expense ratio is 0.35%, holding 63 positions across sectors including Health Care, Consumer Staples, Financials. Inception date: 2006-06-19.
XPH performance shows a YTD return of 15.76%. The 1-year return is 31.38% and the 5-year return is 7.52%. XPH dividend yield stands at 0.78%, paid quarterly.
XPH top holdings include Indivior Pharmaceuticals Inc (3.7%), Xeris Biopharma Holdings Inc (2.8%), Veradermics Inc (2.7%), Pacira Biosciences Inc (2.6%), Eli Lilly & Co (2.6%). Go to all XPH holdings, XPH sectors, or XPH dividends.
XPH can be compared against other funds. Use XPH overlap to find shared positions, or XPH vs another fund for a side-by-side view. XPH alternatives are available via the screener, along with tax-loss harvesting opportunities.